Trial disruption during COVID-19 can take countless forms, from patient retention and missing data challenges, to the need to re-examine endpoint due to new comorbidities or unexpected difficulties with observation. Given this range of potential difficulties, Cytel statisticians and data scientists are prepared to work with you to identify all potential complications, of your trial, and provide a range of options.
Cytel software helps you deliver the impossible
You’ve been asked to conduct research at an unprecedented rate – to deliver the impossible. Cytel’s software portfolio gives you adaptive, Bayesian, and exact tools to go fast and learn.
Design Faster, Smarter COVID-19 Trials: manage uncertainty, improve efficiency, and increase the likelihood of technical success with East.
Accurately Analyze Imperfect COVID-19 Data: Rethink how you leverage data to draw conclusions with the Xact portfolio.
Accelerate Defensible Decisions for Faster COVID-19 Development: Cytel’s OKGO helps you move faster and smarter with a Bayesian framework for structuring decisions in advance.
As the race to find a solution to the coronavirus pandemic intensifies a team of data scientists can become important partners on the journey.
Quickly and Confidently Address COVID-19 Disruptions
You had a strong plan, but the COVID-19 outbreak is disrupting trials globally. Get your enrollment forecast and data analysis plan back on track with EnForeSys and StatXact.